Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 773.75
+77.40 (11.12%)
Jun 15, 2026, 3:29 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 8.12 billion as of June 15, 2026. Its market cap has decreased by -37.59% in one year.
Market Cap
8.12B
Enterprise Value
8.21B
Revenue
8.54B
Ranking
n/a
PE Ratio
17.77
Stock Price
773.75
Market Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 8.12B, an increase of 206.72%. That is a compound annual growth rate of 44.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 8.12B | -0.83% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 9.67B |
| Infinium Pharmachem | 2.98B |
| Quest Laboratories | 1.66B |
| Sotac Pharmaceuticals | 1.23B |
| Zenith Drugs | 752.83M |
| Vilin Bio Med | 655.65M |
| Medicamen Organics | 226.98M |
| Sunrest Lifescience | 145.47M |